In the complex and fast-moving Precision Medicines market clients seek advisors who can provide deep scientific, technical and business insights at a local and global level. Part of the Healthcare and Life Sciences Strategy team, our Precision Medicine practice is a leader in this innovative area of medicine across all thacerapeutic areas, in markets around the world, with all relevant stakeholders and fueled by experience across the value chain.
KPMG in Precision Medicine
Strategy | Deals | Operations

Who we work with
1
Hospital & Healthcare Systems
2
Biopharma Companies
3
Diagnostic & Life Science Tools Companies
4
Commercial, Academic & Hospital Labs
5
Private Investors
Dive into our thinking:
Explore more
Explore our services
-
StrategyThe foundation of Precision Medicine (PM) has evolved from the simplicity of ‘right patient, right drug, right time’ to now encompass cutting edge sequencing, diagnostic, and therapeutic technologies that are impacting clinical outcomes for patients. We help our clients solve their most complex strategic problems on a G-LOCAL level – global strategic focus and local level execution, leveraging our deep market knowledge, and powered by a proprietary database.+3 services
-
01Case StudyDefining an organizational and capabilities roadmap for future market leadership for an oncology medical affairs team in a global biopharma clientDownload now
-
02Case studyGlobal market assessment of the current and future Precision Medicine landscape to optimize future launch strategies for a global biopharma client
-
DealsThe Precision Medicines deal market is one of the most active and dynamic in the Life Sciences industry. Our Precision Medicines team supports clients across the deal continuum, from front-end ideation and planning, to commercial, financial and operational due diligence, and through integration and separation. Our practice has been on the buy and sell-side for deals in the Precision Medicine ecosystem for both corporate and private entities.+3 services
-
01Case studyAssessing the commercial viability and investment thesis of an early-stage oncology diagnostics companyDownload now
-
03Case studyAssessing the commercial viability of assets across multiple indications for a royalty rights opportunityDownload now
-
OperationsOperating a high-performing organization in the Precision Medicine space requires enabling capabilities and functions to bridge strategy through execution, to keep pace with regulatory changes and the evolution of technology. KPMG leverages a holistic approach, helping organizations design and align operating models with business strategy, positioning the mid- and back-office functions of Precision Medicine organizations for performance transformation and commercial success.+3 services
-
01Case studyCurrent state assessment and gap analysis to design an improved maarket access governance model for a global biopharmaDownload now
-
02Case studySetting up COVID-19 testing capabilities for one of the largest reference labs in the United StatesDownload now
Related insights
Life Sciences
Thriving in a converging environment: learn how KPMG can help pharmaceutical, medical device and diagnostic companies turn disruption into opportunity.
Meet our team


